ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
273 | (±¹¿Ü)SCIE | Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG) |
272 | (±¹¿Ü)SCIE | "STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer" |
271 | (±¹¿Ü)SCIE | Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act |
270 | (±¹¿Ü)SCIE | Synergismof AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer |
269 | (±¹¿Ü)SCIE | Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics |
268 | (±¹¿Ü)SCIE | "A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study" |
267 | (±¹¿Ü)SCIE | Transglutaminase 2 Induces Intrinsic EGFR-TKI Resistance in NSCLC Harboring EGFR Sensitive Mutations |
266 | (±¹¿Ü)SCIE | IL-27 Enhances IL-15/IL-18-mediated Activation of Human Natural Killer Cells |
265 | (±¹¿Ü)SCIE | "Predictive factors for treatment response using dual-energy computed tomography in patients with advanced lung adenocarcinoma" |
264 | (±¹¿Ü)SCI | High cripto-1 and Low miR-205 Expression Levels as Prognostic Markers in Early Stage Non-Small Cell Lung Cancer |
Copyright ¨Ï chamc, All rights reserved.